NCT00555230View on ClinicalTrials.gov

Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Rosuvastatin

5mg daily for 4 weeks then step up to 10mg or matching placebo for 52 weeks

DRUG

Placebo

5mg daily for 4 weeks then step up to 10mg or matching placebo for 52 weeks

Trial Locations (1)

Unknown

School of Pharmacy CUHK, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00555230 - Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter